Effect of Tegafur,Gimeracil and Oteracil Potassium Capsules on peripheral blood TPS,sMICA,HIF-1αand Her-2 in advanced cervical cancer
10.3969/j.issn.1005-1678.2016.06.22
- VernacularTitle:替吉奥胶囊对晚期宫颈癌患者外周血TPS、sMICA、HIF－1α及Her－2的影响
- Author:
Mingzhu LI
;
Bo ZHAO
- Publication Type:Journal Article
- Keywords:
TS-1;
TPS;
sMICA;
HIF-1α;
Her-2
- From:
Chinese Journal of Biochemical Pharmaceutics
2016;36(6):82-84
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of Tegafur, Gimeracil and Oteracil Potassium Capsules ( TS-1 ) on peripheral blood tissue polypeptide antigen (TPS), soluble MHC class I chain-related molecules A (sMICA), hypoxia-inducible factor-1 (HIF-1α) and human epidermal growth factor receptor 2 ( Her-2 ) in the treatment of patients with advanced cervical cancer.Methods 80 cases with advanced cervical cancer were selected and divided into two groups, 40 cases in the control group were treated with routine clinical therapy, 40 cases in the experimental group were treated with TS-1.Tumor markers, TPS,sMICA,HIF-1αand Her-2 were compared before and after the treatment.Results Compared with the control group, the levels of tumor antigen TA-4,carcinoembryonic antigen (CEA) and squamous cell carcinoma antigen (SCCA) in the experimental group were lower (P<0.05); the TPS, HIF-1, sMICA and Her-2 were lower (P<0.05), and the total effective rate in the treatment group was higher (P<0.05).Conclusion TS-1 has a obvious clinical efficacy in the treatment of advanced cervical cancer.It is speculated that the possible mechanism may reduce the serum tumor marker levels via reducing the TPS and SMICA, HIF-1 alpha, HER-2 levels.
